We are live on ! Find out more
VNRX icon

VolitionRx Ltd

38 hedge funds and large institutions have $12.2M invested in VolitionRx Ltd in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

345% more call options, than puts

Call options by funds: $316K | Put options by funds: $71K

300% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 3

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

12% more funds holding

Funds holding: 3438 (+4)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.03% less ownership

Funds ownership: 0.54%0.51% (-0.03%)

19% less capital invested

Capital invested by funds: $15.1M → $12.2M (-$2.83M)

Holders
38
Holders Change
+4
Holders Change %
+11.76%
% of All Funds
0.61%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
7
Increased
12
Reduced
3
Closed
3
Calls
$316K
Puts
$71K
Net Calls
+$245K
Net Calls Change
+$34K

VNRX Hedge Fund Activity: Q1 2023 in Review

38 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q1 2023, worth a combined $12.2M — down 19% from $15.1M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new VNRX positions and 3 closed out — a net gain of 4 holders — while 12 added to existing stakes and 3 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $135K. The largest seller was Citadel Advisors, cutting an estimated $129K.

  • 38 institutional investors held VolitionRx Ltd (VNRX) as of Q1 2023, up from 34 in Q4 2022.
  • Funds reported $12.2M of VolitionRx Ltd stock for Q1 2023, down 19% quarter-over-quarter.
  • 7 funds opened new VolitionRx Ltd positions in Q1 2023 and 3 closed out, a net change of +4 holders.
  • The largest VolitionRx Ltd buyer in Q1 2023 was Susquehanna International Group, an estimated $135K added.
  • The largest VolitionRx Ltd seller in Q1 2023 was Citadel Advisors, an estimated $129K sold.

Based on aggregated 13F filings for Q1 2023.